TABLE 1.
Comparison of baseline characteristics among 100 sputum-positive TB patients starting treatment randomized to nutritional supplementsa
| Characteristic | HIV uninfected |
HIV coinfected |
||
|---|---|---|---|---|
| Not supplemented (n = 25) | Supplemented (n = 25) | Not supplemented (n = 24) | Supplemented (n = 26) | |
| Median age (IQR), yr | 30 (27; 36) | 33 (30; 40) | 36 (32; 40) | 36 (32; 45) |
| Male sex, no. (%) | 16 (64.0) | 14 (56.0) | 14 (58.3) | 14 (53.8) |
| Current smoker, no. (%) | 6 (25.0) | 10 (40.0) | 7 (29.2) | 6 (23.1) |
| Drink alcohol (any vs none), no. (%) | 13 (52.0) | 8 (32.0) | 14 (60.9) | 16 (61.5) |
| TB treatment adherence of <95%, no. (%) | 3 (12.0) | 1 (4.0) | 3 (14.3) | 1 (3.9) |
| Median wt at day 0 (IQR), kg | 52 (44.6; 58.8) | 50.7 (48.2; 57.7) | 51.9 (49.2; 56.1) | 52.3 (49.9; 56.6) |
| Median wt at 2 mo (IQR), kg | 55.4 (45.3; 62.9) | 53 (51.0; 60.1) | 54.8 (51.0; 59.8) | 55.1 (49.4; 59.8) |
| Median BMI (IQR), kg/m2 | 18.6 (17.3; 19.6) | 18.0 (16.9; 19.7) | 18.8 (17.4; 20.1) | 19.4 (18.3; 20.5) |
| Median AFA (IQR), cm2 | 4.7 (3.9; 6.1) | 4.8 (5.5; 7.8) | 4.9 (3.8; 7.7) | 5.9 (4.6; 8.5) |
| Median AMA (IQR), cm2 | 41.2 (32.6; 46.6) | 38.2 (33.2; 47.2) | 39.2 (35.2; 41.5) | 43.3 (35.1; 47.7) |
| Median CD4 countb (IQR), cells/μl | 637 (433; 812) | 611 (457; 726) | 168 (64; 338) | 243.5 (140.5; 337.5) |
| SLCO1B1 rs4149032 genotype, no. (%)b | ||||
| CC | 1 (4.2) | 2 (8.0) | 1 (4.2) | 2 (8.0) |
| CT | 10 (41.7) | 13 (60.0) | 13 (54.2) | 11 (44.0) |
| TT | 13 (54.2) | 10 (40.0) | 10 (41.7) | 12 (48.0) |
a
Abbreviations: BMI, body mass index; AFA, arm fat area; AMA, arm muscle area; IQR, interquartile range.
b
The number of observations does not sum to 100 due to missing values.